Malaysian Cradle held a press conference on Monday, announcing the addition of six new partners in their co-investment scheme as well as the reduction of funds allocated for 2017, from MYR 30 million to MYR 22 million.
Stepping towards becoming a leading global pharmaceutical enterprise, Luye Pharma Group Ltd. has made its second acquisition - Swiss's Acino, a transdermal drug delivery system business.
Singapore-based investment firm Jungle Ventures has announced the closing of its second round fund which has reached US$100 million. The round was participated by Temasek Holdings, International Finance Corporation, among some.